Pentasa Capsule
Product Images NDC 54092-191

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentasa (NDC 54092-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pentasa 01)

Chemical structure of mesalamine, the active ingredient in Pentasa 250 mg and 500 mg oral capsules by Takeda Pharmaceuticals America, Inc. The structure shows a benzene ring with amino, hydroxyl, and carboxyl functional groups attached.*

FDA Label Image

Principal Display Panel (250 mg Capsule Bottle Label)

Label for Pentasa (mesalamine) extended-release capsules, 250 mg strength. The label indicates a bottle containing 240 capsules. The product is distributed by Takeda Pharmaceuticals America, Inc. and designated Rx only. Storage and usage warnings are visible, including dosage instructions, child safety, and temperature controls.*

FDA Label Image

Principal Display Panel (500 mg Capsule Bottle Label)

Label for Pentasa (mesalamine) extended-release capsules, 500 mg strength, in a 120 capsule package. The label shows it is a prescription drug distributed by Takeda Pharmaceuticals America, Inc. The label includes dosage form, strength, package size, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.